Randomized, Placebo-controlled Crossover Study of Dalfampridine Extended-release in Transverse Myelitis

BACKGROUND: Dalfampridine has the potential to be effective in patients with transverse myelitis (TM) as this rare disorder shares some clinical and pathogenic similarities with multiple sclerosis. METHODS: This is a randomized, double-blind, placebo-controlled crossover study of dalfampridine exten...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mult Scler J Exp Transl Clin
Autori principali: Schwartz, Kateryna, Wymbs, Nicholas F, Huang, Hwa, Mealy, Maureen A, Pardo, Carlos A, Zackowski, Kathleen, Levy, Michael
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2017
Soggetti:
Original Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5731631/
https://ncbi.nlm.nih.gov/pubmed/29270309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217317740145
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi